Ayala Pharmaceuticals Inc (ADXS)

[JB-22]

The fact is the company is run by incompetent management hence the selling. The science is better than good thus far, but these guys have tripped over their feet every step of the way.

They have zero ability to communicate effectively! Which creates doubt and doubt equals sells.

Another example is this last conference rehashing old info in a poster presentation and then having a reception screams to me of desperation looking for partners.

At this point we can hope this more of a CALA scenario than what it actually looks like - a rudderless ship.